- $1.66bn
- $1.87bn
- $601.79m
- 71
- 89
- 55
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 400 | 479 | 458 | 474 | 481 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 389 | 372 | 522 | 476 | 464 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 193 | 145 | 302 | 236 | 194 |
Provision for Income Taxes | |||||
Net Income After Taxes | 159 | 122 | 242 | 192 | 159 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 159 | 122 | 242 | 192 | 159 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 159 | 119 | 232 | 182 | 149 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.07 | 1.9 | 3.62 | 3.05 | 2.56 |
Dividends per Share |